US Patent Issued to EURISKO BIOSCIENCES on Sept. 1 for "Wearable medical monitoring device with microneedle array and artificial intelligence (AI)-based health anomaly detection" (Florida Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,549, issued on Sept. 1, was assigned to EURISKO BIOSCIENCES LLC (Tallahassee, Fla.).

"Wearable medical monitoring device with microneedle array and artificial intelligence (AI)-based health anomaly detection" was invented by David Wimberly (Tallahassee, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A wearable medical monitoring device comprises a microneedle array configured to extract interstitial or capillary fluid from a user, biosensors configured to detect biomarkers including glucose and complete blood count parameters such as white blood cells, red blood cells, hemoglobin, hematocrit, and platelet count, a microprocessor configured to g...